Article
Design of a targeted next-generation DNA sequencing panel for pediatric T-cell lymphoblastic lymphoma to unravel biology and optimize treatment.
Genes, chromosomes & cancer - 1 Aug 2022
Ruether Charlotte, Wuensch Christian, Randau Gerrit, Michgehl Ulf, Trautmann Marcel, Hartmann Wolfgang, Sandmann Sarah, Dugas Martin, Khanam Tasneem, Burkhardt Birgit
Abstract excerpt
Low incidence and molecular heterogeneity of pediatric T-cell lymphoblastic lymphoma (T-LBL) require an international, large-scale effort to identify novel clinical biomarkers. The ongoing international clinical trial LBL2018 (NCT04043494) represents an ideal opportunity to implement a common analytic approach. Targeted next-generation sequencing is well-suited for this purpose; however, selection of relevant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
